Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE.
Haotian ZhouXiaozhen ZhaoRuijun ZhangMiao MiaoWenwen PeiZijun LiYimin LiJing HeZhan-Guo LiXiaolin SunPublished in: Signal transduction and targeted therapy (2023)